Lucid Diagnostics Inc.

LUCD ·Healthcare, Medical Devices, United States
Financial Statements › Balance Sheet
Annual Quarterly

Balance Sheet

Line Item FY2025 FY2024 FY2023 FY2022 FY2021 FY2020
Assets
Cash & Equivalents — $22.4M $18.9M $22.5M $53.7M —
Accounts Receivable $643.0K $45.0K $45.0K $17.0K $200.0K —
Inventory $353.0K $341.0K $278.0K $111.0K — —
Total Current Assets $37.5M $25.1M $22.1M $24.4M $57.3M $1.4M
Property, Plant & Equipment $809.0K $1.1M $1.3M $1.6M $971.0K —
Goodwill — — — — — —
Intangible Assets (Excl. Goodwill) $315.0K $736.0K $1.4M $3.4M — —
Total Assets $40.4M $30.7M $27.3M $32.5M $59.0M $2.2M
Liabilities
Accounts Payable $970.0K $1.2M $1.1M $1.1M $1.5M $2.1M
Total Current Liabilities $28.6M $23.5M $29.4M $8.4M $4.3M —
Long-Term Debt — — — — — —
Total Liabilities $29.5M $25.3M $29.6M $9.5M $4.3M $15.7M
Stockholders' Equity
Retained Earnings $-274.3M $-203.8M $-150.7M $-98.1M $-41.9M $-13.8M
Total Stockholders' Equity $10.9M $5.4M $-2.3M $23.0M $54.7M $-13.5M